Effectiveness of Outreach Clinical Mentoring on Retention in Care and Viral Suppression among HIV Positive Young Persons on Art in North Central Nigeria


Authors : Ogwuche John Igoche; Ruth Amarachi Ogbonna; Ejila Moses Onehi; Adamu Ibrahim Alhasan; Attah Peter; Inyang Nsikak Isaac

Volume/Issue : Volume 9 - 2024, Issue 5 - May

Google Scholar : https://tinyurl.com/yvhs9k27

Scribd : https://tinyurl.com/mrr895yn

DOI : https://doi.org/10.38124/ijisrt/IJISRT24MAY2401

Abstract : Introduction Sexual and reproductive health challenges vis-à-vis Human immunodeficiency virus/Acquired immune deficiency syndrome, constitute a complex phenomenon in young persons. These health complexes have been shown to adversely affect the disclosure of their positive status, their adherence to medications or retention in care and overall quality of life. This study was meant to determine the effectiveness of deliberate clinical mentoring on retention in care, measured by the rate of interruption in treatment and viral suppression among young persons on anti-retroviral therapy.  Methods This study employed a facility-based quasi- experimental design. A multi-stage sampling technique was used to select study participants. The three senatorial zones of Nasarawa state were selected through a purposive sampling method at stage one. One Local Government Area was selected from each of the three senatorial zones through simple random sampling technique at stage two. Five health care facilities were randomly selected from each of the three selected Local Government Areas through balloting at stage three. Baseline data was collected at the beginning of the study; mid-term data mid- way into the study and post-intervention data was collected at the end of the study. The respondents/mentees were mentored for a period of eight months.  Results Difference in means of interruption in treatment rates at baseline and at midterm, which is an estimate of the amount by which intervention changed the outcome was – 0.69605 with a p-value of 0.359. Mean differences in interruption in treatment rates pre- and post-intervention was 0.7333 with a p-value of 0.033, which was statistically significant. In a similar vein, mean differences in viral suppression rates at start of study and mid-term on the one hand, and then pre- and post-intervention on the other hand, were respectively 4.80000 and 3.40000. The corresponding p-values were 0.235 and 0.174, which were not statistically significant.  Conclusion This study showed 100% retention among young persons on anti-retroviral therapy following 8 months of meticulous outreach clinical mentoring. The study also showed improvements in viral suppression rates, but the extent statistically, was not significant. Clinical mentoring should therefore, be prioritized and strengthened for better clinical care outcomes in positive young persons on anti retroviral therapy.

Keywords : Clinical Mentoring, Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, Interruption in Treatment, Viral Load, Young Persons.

References :

  1. UNAIDS. UNAIDS Data 2017. Available from: www.unaids.org/en/resources/documents/2017/2017_data_book
  2. Bartlett JG. Ten Years of HAART: Foundation for the Future. Available from: https://www.medscape.org/viewarticle/523119.
  3. Palmisano L, Vella S: A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-48. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21430338.
  4. Nigeria FGO. National HIV and AIDS Strategic Plan 2017-2021. 2017.
  5. WHO. Strengthening the adolescent component of HIV/AIDS and reproductive health programmes: a training course for public health managers. Geneva2011.
  6. Sobze MS, Tiotsia AT, Dongho GB, Tankui GA, Fokam J, Tsi KA, et al. Youth Awareness on Sexually Transmitted Infections, HIV and AIDS in Secondary Schools in the Dschang Municipality (Cameroon): The Mobile Caravan Project. J Public Health Afr. 2016;7(2):614.Available from: http://www.ncbi.nlm.nih.gov/pubmed/28299163.
  7. WHO. Regional Atlas on Adolescent and Youth Health - the Health Status and Trend of Adolescent and Youth in Africa. . Brazzaville World Health Organisation 2017.
  8. Morris JL, Hamid R. Adolescent sexual and reproductive health: The global challenges. International Journal of Gynecology & Obstetrics. 2015;131(S1):S40-S42.Available from: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1016/j.ijgo.2015.02.006.
  9. Esther AE, Prisca Z, Ayuba IZ. Sexual and Reproductive health challenges of Adolescent males and females in some communities of Plateau State, Nigeria. International Journal of Psychology and Behavioural Sciences. 2017;7(2):55-60.
  10. Rachel CV, Brittany MM, Sonia L. Mental health challenges among adolescents living with HIV. Journal of the International AIDS Society. 2017;20(S3):21497.Available from: https://onlinelibrary.wiley.com/doi/abs/10.7448/IAS.20.4.21497.
  11. Arrive E, Dicko F, Amghar H, Aka AE, Dior H, Bouah B, et al. HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One. 2012;7(3):e33690.Available from: http://www.ncbi.nlm.nih.gov/pubmed/22457782.
  12. Nöstlinger C, Bakeera-Kitaka S, Buyze J, Loos J, Buvé A. Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa. AIDS care. 2015;27(sup1):36-46.Available from: https://doi.org/10.1080/09540121.2015.1051501.
  13. Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc. 2013;16:1-19.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782478.
  14. Laughton B, Cornell M, Boivin M, Van Rie A. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc. 2013;16:18603.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782482.
  15. Bhimma R, Purswani MU, Kala U. Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc. 2013;16:18596.Available from: http://www.ncbi.nlm.nih.gov/pubmed/23782479.
  16. Lucien DD, Chloé GL, Chloe AT, Lorna R, Marcel Y, Sophie D, et al. Transition from paediatric to adult care of adolescents living with HIV in sub‐Saharan Africa: challenges, youth‐friendly models, and outcomes. Journal of the International AIDS Society. 2017;20(S3):34-49.Available from: https://onlinelibrary.wiley.com/doi/abs/10.7448/IAS.20.4.21528.
  17. Slogrove AL, Schomaker M, Davies MA, Williams P. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med.
  18. UNAIDS. AID SInfo 2022 [Available from: aidsinfo.unaids.org]
  19. UNAIDS. AIDS Info 2018 [Available from: aidsinfo.unaids.org]
  20. Ihvnigeria.org>nasarawa-state-surge project.org
  21. www.blueprint.ng>hiv-aids-nasaca
  22. McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of HAART in low and middle-income countries: a systematic review. Bull World Health Organ 2013; 91 : 377-85.
  23. Boender TS, Sigaloff KCE, McMahon JH. Long-term virological outcomes of first-line ART for HIV-1 in low and middle-income countries: a systematic review and meta analysis. Clin Infect Dis 2015; 61: 1453-61.
  24. Taiwo BO, Idoko JA, Welty LJ. Assessing the virologic and adherence benefits patient-selected HIV treatment partners in a resource-limited setting. JAIDS J Acquir Immune DeficSyndr 2010; 54: 85-92.
  25. Abah IO, Darin MK, Ebonyi AO. Patterns and predictors of first-line ART modifications in HIV-1-infected adults in a large urban outpatient cohort in Nigeria. J Int Assoc Provide AIDS Care 2015; 14(4): 348-54.
  26. Agbaji OO, Abah IO, Falang KD. Treatment discontinuation in adult HIV-infected patients on first-line ART in Nigeria. Curr HIV Res 2015; 13: 184-92.
  27. UNAIDS. 90-90-90 - An Ambitious Treatment Target to Help End the Aids Epidemic. Geneva: UNAIDS 2017.
  28. World Health Organisation. Supervisory Checklist for the Monitoring/Supervision of IMCI activities. Geneva:WHO; 2005. Available from www.emro.who.int/cah/pdf/pak-supervisory checklist.pdf.]
  29. Deress T, Jemal M, Girma M, Adane K. Knowledge, attitude and practice of waste handlers about medical waste management in Debre Markos town health care facilities, northwest Ethiopia. BMC Res Notes, 2019;12:146-151.
  30. Dalson K, Moses RK, Asiphas O, Florence M, Dathan M. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya. Journal of the International AIDS Society 2017, 20(Suppl 4):21673
  31. Boyd MA, Fwoloshi S, Minchella PA, Simpungwe J, Siansalama T, Barradas DT, et al. National HIV clinical mentorship program: Enabling Zambia to accelerate control of the HIV epidemic. PLOS Glob Public Health 2022; 2(2) e0000074. https://doi.org/10.1371/journal.pgph.0000074

Introduction Sexual and reproductive health challenges vis-à-vis Human immunodeficiency virus/Acquired immune deficiency syndrome, constitute a complex phenomenon in young persons. These health complexes have been shown to adversely affect the disclosure of their positive status, their adherence to medications or retention in care and overall quality of life. This study was meant to determine the effectiveness of deliberate clinical mentoring on retention in care, measured by the rate of interruption in treatment and viral suppression among young persons on anti-retroviral therapy.  Methods This study employed a facility-based quasi- experimental design. A multi-stage sampling technique was used to select study participants. The three senatorial zones of Nasarawa state were selected through a purposive sampling method at stage one. One Local Government Area was selected from each of the three senatorial zones through simple random sampling technique at stage two. Five health care facilities were randomly selected from each of the three selected Local Government Areas through balloting at stage three. Baseline data was collected at the beginning of the study; mid-term data mid- way into the study and post-intervention data was collected at the end of the study. The respondents/mentees were mentored for a period of eight months.  Results Difference in means of interruption in treatment rates at baseline and at midterm, which is an estimate of the amount by which intervention changed the outcome was – 0.69605 with a p-value of 0.359. Mean differences in interruption in treatment rates pre- and post-intervention was 0.7333 with a p-value of 0.033, which was statistically significant. In a similar vein, mean differences in viral suppression rates at start of study and mid-term on the one hand, and then pre- and post-intervention on the other hand, were respectively 4.80000 and 3.40000. The corresponding p-values were 0.235 and 0.174, which were not statistically significant.  Conclusion This study showed 100% retention among young persons on anti-retroviral therapy following 8 months of meticulous outreach clinical mentoring. The study also showed improvements in viral suppression rates, but the extent statistically, was not significant. Clinical mentoring should therefore, be prioritized and strengthened for better clinical care outcomes in positive young persons on anti retroviral therapy.

Keywords : Clinical Mentoring, Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome, Interruption in Treatment, Viral Load, Young Persons.

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe